DNA Today is a multi-award winning podcast and radio show exploring how genetics impacts our health.

Host/Producer Kira Dineen interviews leaders in genetics including genetic counselors, researchers, physicians and patient advocates.

New episodes every Friday.

DNA Today is broadcast Fridays at 10:30am EST on WHUS 91.7 FM in Connecticut.

#407 NFL and Kansas City Chiefs Star Art Still on the Missed Signs of Hereditary Amyloidosis

#407 NFL and Kansas City Chiefs Star Art Still on the Missed Signs of Hereditary Amyloidosis

What happens when the symptoms of a genetic condition look like the lasting effects of a professional football career?

Former NFL defensive end and Kansas City Chiefs star Art Still spent decades attributing carpal tunnel syndrome, trigger finger, back problems, joint and tendon injuries, neuropathy, and other health concerns to football, aging, and ordinary wear and tear. Even when he developed atrial fibrillation, Art’s lifelong discipline and athlete mentality made him believe he could manage his health on his own.

Art and his wife, Liz Still, join host Kira Dineen to share how those seemingly disconnected symptoms were eventually traced to hereditary transthyretin amyloidosis, also known as hereditary ATTR or hATTR amyloidosis.

During evaluations through the NFL Player Care Foundation wellness program, Art’s healthcare providers looked beyond his individual symptoms and asked about his family health history. That conversation revealed a striking pattern: relatives with serious cardiac, neurologic, and mobility-related conditions, including Art’s older brother, who received a heart transplant, and his nephew, who lived with sickle cell disease and had previously tested positive for the same TTR variant.

Genetic testing confirmed that Art carries the V122I variant, also called p.Val142Ile or V142I, in the TTR gene. This variant is found in approximately 3–4% of Black Americans, or about 1 in 25, although carrying it does not necessarily mean someone will develop amyloidosis.

For Art and Liz, the diagnosis provided answers, but it also raised questions for their 11 children, 28th grandchild on the way, and extended family. They discuss navigating family conversations about inherited health risks, the value of genetic testing, Art’s evolving trust in healthcare, and why following a treatment plan matters.

Through their nonprofit, Still 4 Life, Art and Liz now offer free community presentations focused on awareness, earlier detection, family health history, and self-advocacy. Their goal is to make complicated medical information easier to understand and reach people who may otherwise dismiss their symptoms or hesitate to seek care.

Episode Discussion Topics

  • How Art’s “no pain, no gain” athlete mentality shaped his response to symptoms

  • Why professional athletes may normalize pain and avoid disclosing injuries

  • The symptoms Art initially attributed to football, including carpal tunnel syndrome, trigger finger, back problems, neuropathy, joint and tendon injuries, and a torn biceps

  • Why a torn biceps can be a potential warning sign of transthyretin amyloidosis

  • Liz’s early belief that Art’s symptoms were natural consequences of his football career

  • When Art’s cardiac symptoms caused Liz to realize something else might be happening

  • Art’s history of atrial fibrillation and his initial resistance to medication

  • His evaluations through the NFL Player Care Foundation wellness program

  • The family health history questions that helped connect Art’s seemingly unrelated symptoms

    • His brother’s heart transplant

    • His nephew’s sickle cell disease, amyloidosis, and earlier genetic test result

    • Why Art’s nephew was originally evaluated for Marfan syndrome

  • How genetic testing identified Art’s V122I TTR variant

  • The relief of finally understanding the cause of Art’s health problems

  • How the diagnosis changed conversations with their 11 children and extended family

  • Why family health history may be one of the most valuable legacies a family can preserve

  • The difference between carrying a genetic variant and developing symptoms

  • Why ancestry can help identify risk but should not be used to exclude someone from consideration

  • Art’s mistrust of the medical and pharmaceutical industries, and how his perspective evolved

  • What happened when Art reduced and stopped his heart medication without medical guidance

  • Why finding a healthcare team that explains the purpose of treatment is so important

  • How Liz advocated for Art when she realized he was not following his prescribed treatment plan

  • The importance of asking questions and making healthcare decisions with qualified clinicians

  • How Art uses humor and personal storytelling to make medical information approachable

  • Why Art and Liz founded Still 4 Life

  • Meeting people where they are through free community education

  • Encouraging families to discuss their health history and advocate for one another

  • Turning a hereditary diagnosis into a game plan for a healthier community

About Hereditary ATTR Amyloidosis

Hereditary transthyretin amyloidosis is caused by a disease-associated variant in the TTR gene. The variant makes the transthyretin protein more likely to misfold and accumulate as amyloid deposits in organs and tissues.

Depending on the individual and the specific variant, hereditary ATTR amyloidosis can affect the heart, peripheral nerves, autonomic nervous system, digestive system, kidneys, and other parts of the body. Possible warning signs can include cardiomyopathy, heart failure, irregular heart rhythms, neuropathy, carpal tunnel syndrome, spinal stenosis, tendon injuries, swelling, and digestive symptoms.

Because these concerns are often evaluated by different specialists, and may be attributed to more common conditions, the underlying diagnosis can be missed for years.

Art carries the V122I variant, which is also referred to as V142I or p.Val142Ile under current genetic nomenclature. It is particularly prevalent among people with West African ancestry and is found in approximately 3–4% of Black Americans; however, genetic variants do not conform neatly to racial categories. 

Not everyone who inherits a disease-associated TTR variant develops amyloidosis. Anyone concerned about personal symptoms or family history should discuss appropriate evaluation and testing with a qualified healthcare professional.

About Art Still

Art Still is a former NFL defensive end, College Football Hall of Fame inductee, and rare disease advocate. He was selected by the Kansas City Chiefs with the second overall pick in the 1978 NFL Draft and played 12 professional seasons with the Chiefs and Buffalo Bills.

During his decade in Kansas City, Art earned four Pro Bowl selections and was named the Chiefs’ Most Valuable Player twice. After years of orthopedic, neurologic, and cardiac symptoms, Art was diagnosed with hereditary transthyretin amyloidosis in 2023.

Art now uses the same team-oriented mindset that shaped his football career to educate communities about amyloidosis, family health history, early detection, and self-advocacy.

About Liz Still

Liz Still is Art’s wife, care partner, and advocacy partner. She initially believed that many of Art’s symptoms resulted from his years in professional football. When his cardiac problems became more serious, she recognized that something else might be happening and became an important advocate throughout his diagnostic and treatment journey.

Following Art’s hereditary amyloidosis diagnosis, Liz helped research the condition, understand its implications for their family, and communicate the information to their children and relatives. She now works alongside Art through Still 4 Life, helping families recognize the importance of asking questions, sharing family health history, and advocating for the people they love.

Still 4 Life

Art and Liz founded Still 4 Life to increase awareness and encourage earlier detection of amyloidosis and other rare diseases.

Through free community presentations, they share Art’s personal experience in approachable language and encourage people to:

  • Learn and document their family health history

  • Discuss patterns of illness with relatives

  • Pay attention to symptoms that may appear unrelated

  • Ask healthcare providers questions

  • Advocate for themselves and their loved ones

  • Learn whether a genetics evaluation may be appropriate

  • Seek medical guidance before changing prescribed treatment

Community organizations, healthcare professionals, and other groups interested in hosting an educational presentation can connect with Art and Liz through Still4Life.org.

Resources

More Cardiac Genetics Episodes of DNA Today

More Celebrity Interviews on DNA Today

Connect with DNA Today:

You never have to wait long for a new episode of DNA Today, we release episodes every Friday! In the meantime, explore our library of over 400 episodes on Apple Podcasts, Spotify, DNAToday.com, or wherever you listen to podcasts. Just search “DNA Today.”

Prefer to watch? The video version of this episode is available on our YouTube channel and DNAToday.com. Select episodes are filmed in person, including some at the iconic NBCUniversal studios.

Discover more podcasts exploring genetics, genomics, medicine, and science from our network, Gene Pool Media: The Science Podcast Network.

DNA Today is hosted and executive produced by Kira Dineen, MS, LCGC, CG(ASCP)CM. Liv Davidson is our Social Media Lead and Eric Knaus is our Digital Marketing and Automation Lead. 

Follow us at @DNATodayPodcast on all platforms including Instagram, X, BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com

Questions, partnership inquiries, and guest pitches can be sent to info@DNAToday.com.

#406 Mock Teratogen Genetic Counseling Session: Ozempic, Zoloft, Xanax, and Metformin

#406 Mock Teratogen Genetic Counseling Session: Ozempic, Zoloft, Xanax, and Metformin